Have a personal or library account? Click to login
Personalization of thiopurine therapy: Current recommendations and future perspectives Cover

Personalization of thiopurine therapy: Current recommendations and future perspectives

Acta Pharmaceutica
Volume 74 (2024): Issue 3 (September 2024)
By: Dunja Urbančič,  Flaka Pasha,  Alenka Šmid and  Irena Mlinarič-Raščan  
Open Access
|Sep 2024

Authors

Dunja Urbančič

University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia

Flaka Pasha

University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia
University of Prishtina “Hasan Prishtina”, Faculty of Medicine Department of Pharmacology with Toxicology, and Clinical Pharmacology, Prishtina, Kosovo

Alenka Šmid

University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia

Irena Mlinarič-Raščan

irena.mlinaric@ffa.uni-lj.si

University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia
DOI: https://doi.org/10.2478/acph-2024-0030 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 355 - 381
Accepted on: Jun 10, 2024
Published on: Sep 14, 2024
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
thiopurines,
TPMT,
NUDT15,
personalized medicine,
therapeutic drug monitoring
Related subjects:
Pharmacy,
Pharmacy, other

© 2024 Dunja Urbančič, Flaka Pasha, Alenka Šmid, Irena Mlinarič-Raščan, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 74 (2024): Issue 3 (September 2024)Next article